Greig; Nigel H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Greig; Nigel H..The latest application filed is for "methods of delivering a neuroprotective polypeptide to the central nervous system".

Company Profile

7.23.27

Greig; Nigel H. - Phoenix MD
Greig; Nigel H - Phoenix MD
Greig, Nigel H. - Silver Spring MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Thalidomide analogs and methods of use Grant 11,440,880 - Greig , et al. September 13, 2	2022-09-13
Methods Of Delivering A Neuroprotective Polypeptide To The Central Nervous System App 20220265563 - Kim; Dong Seok ; et al.	2022-08-25
Methods of delivering a neuroprotective polypeptide to the central nervous system Grant 11,273,130 - Kim , et al. March 15, 2	2022-03-15
GLP-1, exendin-4, peptide analogs and uses thereof Grant 10,941,187 - Greig , et al. March 9, 2	2021-03-09
Thalidomide Analogs And Methods Of Use App 20210047267 - Greig; Nigel H. ; et al.	2021-02-18
Thalidomide analogs and methods of use Grant 10,836,721 - Greig , et al. November 17, 2	2020-11-17
Thalidomide Analogs And Methods Of Use App 20200325102 - Greig; Nigel H. ; et al.	2020-10-15
Thalidomide analogs and methods of use Grant 10,730,835 - Greig , et al.	2020-08-04
Methods Of Delivering A Neuroprotective Polypeptide To The Central Nervous System App 20200046645 - Kim; Dong Seok ; et al.	2020-02-13
Thio compounds Grant 10,220,028 - Greig , et al.	2019-03-05
Thalidomide Analogs And Methods Of Use App 20180273472 - Greig; Nigel H. ; et al.	2018-09-27
Thio Compounds App 20170182022 - Greig; Nigel H. ; et al.	2017-06-29
Thio compounds Grant 9,623,020 - Greig , et al. April 18, 2	2017-04-18
Thio Compounds App 20150359784 - Greig; Nigel H. ; et al.	2015-12-17
Glp-1, Exendin-4, Peptide Analogs And Uses Thereof App 20150072930 - Greig; Nigel H. ; et al.	2015-03-12
Thio compounds Grant 8,927,725 - Greig , et al. January 6, 2	2015-01-06
Thalidomide Analogs App 20140309436 - Greig; Nigel H. ; et al.	2014-10-16
GLP-1, exendin-4, peptide analogs and uses thereof Grant 8,853,160 - Greig , et al. October 7, 2	2014-10-07
Thalidomide analogs Grant 8,853,253 - Greig , et al. October 7, 2	2014-10-07
Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof Grant 8,691,864 - Greig , et al. April 8, 2	2014-04-08
Thalidomide analogs Grant 8,546,430 - Greig , et al. October 1, 2	2013-10-01
Thio Compounds App 20130143922 - Greig; Nigel H. ; et al.	2013-06-06
Thalidomide Analogs App 20130035363 - Greig; Nigel H. ; et al.	2013-02-07
Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof App 20120295946 - Greig; Nigel H. ; et al.	2012-11-22
Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof Grant 8,258,172 - Greig , et al. September 4, 2	2012-09-04
Thalidomide Analogs App 20110245210 - Greig; Nigel H. ; et al.	2011-10-06
Thalidomide analogs Grant 7,973,057 - Greig , et al. July 5, 2	2011-07-05
Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof App 20110021594 - Greig; Nigel H. ; et al.	2011-01-27
Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof Grant 7,786,162 - Greig , et al. August 31, 2	2010-08-31
Method of reducing amyloid-beta peptide levels using a bisdioxopiperazine App 20100144704 - Greig; Nigel H. ; et al.	2010-06-10
Method Of Treating Or Preventing Oxidative Stress-related Disease App 20100105707 - Greig; Nigel H. ; et al.	2010-04-29
Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof App 20090131501 - Greig; Nigel H. ; et al.	2009-05-21
Tetrahydrobenzothiazole Analogues As Neuroprotective Agents App 20080319032 - Greig; Nigel H ; et al.	2008-12-25
Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof Grant 7,153,882 - Greig , et al. December 26, 2	2006-12-26
Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof App 20060270729 - Greig; Nigel H. ; et al.	2006-11-30
Thalidomide analogs App 20060211728 - Greig; Nigel H. ; et al.	2006-09-21
Compound useful in the treatment or prevention of cognitive disorders associated with diabetes and associated methods App 20060105940 - Greig; Nigel H. ; et al.	2006-05-18
Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof App 20040138282 - Greig, Nigel H. ; et al.	2004-07-15
Tetrahydrobenzothiazole analogues as neuroprotective agents App 20040067991 - Greig, Nigel H ; et al.	2004-04-08
Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias Grant 6,683,105 - Greig , et al. January 27, 2	2004-01-27
Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias App 20020094999 - Greig, Nigel H. ; et al.	2002-07-18
Targeting of liposomes to the blood-brain barrier App 20020025313 - Micklus, Michael J. ; et al.	2002-02-28
Method for treating cognitive disorders with phenserine Grant 5,409,948 - Greig , et al. * April 25, 1	1995-04-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.